Evaluation of Stroke Frequency in COVID-19 Patients

Objective: Neurological symptoms occur due to central and peripheral nervous system involvement with different mechanisms in coronavirus disease 2019 (COVID-19). Microvascular thrombosis develops prothrombotic activation along the increase cytokines COVID-19 infection. We aimed investigate incidence of cerebrovascular concomitant risk factors positive patients.Materials Methods: Acute temporally related diseases a diagnosis were evaluated. Cerebrovascular events assessed 4 groups as ischemic hemorrhagic events, transient attacks, cerebral venous thrombosis. Risk for these patients also assessed, which are high examined.Results: Of 1000 Ischemic and/or attack found 14 (1.4%). The most common fever respiratory distress acute stroke diagnosed COVID-19.Conclusion: increases multiple factors. Close follow-up should be performed more carefully, especially pulmonary stroke, because mortality is likely higher.